Wah Yuen To

Title: Innovations by Wah Yuen To

Introduction

Wah Yuen To is an accomplished inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on addressing critical health issues.

Latest Patents

Wah Yuen To's latest patents include groundbreaking inventions such as Complement factor D antagonist antibodies and conjugates thereof. This invention provides antagonizing antibodies that bind to complement factor D (CFD), along with methods for their therapeutic use. These anti-CFD antibodies can be utilized alone or in combination with other therapeutics to treat age-related macular degeneration and various other diseases. Another notable patent involves antibodies and conjugates thereof, specifically anti-VEGF-A antibodies. Some embodiments of these antibodies can be conjugated to a moiety, such as a HEMA-PC polymer, which may retain or enhance antibody activity. This innovation is particularly useful for treating diabetic retinopathy.

Career Highlights

Wah Yuen To is currently associated with Kodiak Sciences Inc., where he continues to advance his research and development efforts. His work has positioned him as a key player in the biotechnology sector, contributing to innovative solutions for complex medical challenges.

Collaborations

Wah Yuen To collaborates with esteemed colleagues, including Daniel Victor Perlroth and Hong Liang. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.

Conclusion

Wah Yuen To's contributions to biotechnology through his patents and collaborations highlight his commitment to improving healthcare solutions. His work exemplifies the impact of innovation in addressing significant medical issues.